Acasti Pharma Inc. ACST
At closeOct 25, 2024, 4:00 PM EDT
52-week range unavailable
- Market cap
- 34.17M
- Shares out
- 10.14M
- Forward P/E
- -2.67
- Volume
- 27.68K
- Open
- 3.43
- Previous close
- 3.37
- Day's range
- 3.20 – 3.45
- Beta
- 1.52
- Analysts
- Buy
- Price target
- 7.97 (+136.5%)
- Earnings date
- Nov 11, 2024
2Y -0.32 (-8.89%)
Key statistics
- Enterprise value
- 13.14M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.58
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -5.58M
- Total cash
- 19.41M
- Total debt
- 0
- Return on equity
- -18.56%
- Short % of float
- 1.93%
- 50-day average
- 3.05
- 200-day average
- 2.99
Analyst view
Consensus: buy
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 11, 2024
Expected Nov 11, 2024. Consensus EPS estimate -0.46.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2024 | Sep 1, 2024 | -0.34 | — | — | — |
| Aug 9, 2024 | Jun 1, 2024 | -0.28 | — | — | — |
| Jun 21, 2024 | Mar 1, 2024 | -0.35 | — | — | — |
| Feb 12, 2024 | Dec 1, 2023 | -0.30 | — | — | — |
| Nov 13, 2023 | Sep 1, 2023 | -0.29 | — | — | — |
| Aug 11, 2023 | Jun 1, 2023 | -0.63 | — | — | — |
About Acasti Pharma Inc.
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- acastipharma.com
News
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session 
Earnings Scheduled For February 14, 2023 
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket 
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session - Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022 
Stocks That Hit 52-Week Lows On Friday 
Stocks That Hit 52-Week Lows On Wednesday 
Earnings Scheduled For November 14, 2022
Your note
Sign in to keep a note on ACST — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Kohli (Prashant) | Senior Officer of Issuer | Opening Balance-Initial SEDI Report | Sep 8, 2022 | 128,138 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Adar1 Capital Management, LLC | 0.00% | 959,571 | 3.23M | Jun 29, 2024 |
| AIGH Capital Management LLC | 0.00% | 641,083 | 2.16M | Jun 29, 2024 |
| Bank of America Corporation | 0.00% | 494,698 | 1.67M | Jun 29, 2024 |
| Susquehanna International Group, LLP | 0.00% | 37,793 | 127.36K | Jun 29, 2024 |
| Royal Bank of Canada | 0.00% | 6,584 | 22.19K | Jun 29, 2024 |
| National Bank of Canada/FI | 0.00% | 2,901 | 9.78K | Jun 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.00% | 3,058 | 10.30K | Aug 30, 2024 |
| Series Portfolios Tr-Unusual Whales Subversive Republican Trading ETF | 0.00% | 309 | 1.04K | Jun 29, 2024 |